Ainos, Inc. (AIMD)

Market Cap	12.06M +45.3%
Revenue (ttm)	18,111 -82.9%
Net Income	-13.94M
EPS	-2.80
Shares Out	7.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,398
Open	1.700
Previous Close	1.700
Day's Range	1.630 - 1.740
52-Week Range	1.260 - 4.500
Beta	2.31
Analysts	Buy
Price Target	13,537.51 (+815,510.92%)
Earnings Date	May 13, 2026

About AIMD

Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal he...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1984
• Employees: 41
• Stock Exchange: NASDAQ
• Ticker Symbol: AIMD
• Website: https://www.ainos.com

Financial Performance

In 2025, Ainos's revenue was $124,157, an increase of 498.95% compared to the previous year's $20,729. Losses were -$14.77 million, -0.62% less than in 2024.

Analyst Summary

According to one analyst, the rating for AIMD stock is "Buy" and the 12-month stock price target is $13,537.51.

Price Target

$13,537.51

(815,510.92% upside)

Analyst Consensus: Buy